Title
GRADE guidelines: 4. Rating the quality of evidence - Study limitations (risk of bias)
Date Issued
01 January 2011
Access level
metadata only access
Resource Type
journal article
Author(s)
Guyatt G.H.
Oxman A.D.
Vist G.
Kunz R.
Brozek J.
Alonso-Coello P.
Akl E.A.
Djulbegovic B.
Falck-Ytter Y.
Norris S.L.
Williams J.W.
Atkins D.
Meerpohl J.
Schünemann H.J.
Mayo Clinic
Publisher(s)
Elsevier USA
Abstract
In the GRADE approach, randomized trials start as high-quality evidence and observational studies as low-quality evidence, but both can be rated down if most of the relevant evidence comes from studies that suffer from a high risk of bias. Well-established limitations of randomized trials include failure to conceal allocation, failure to blind, loss to follow-up, and failure to appropriately consider the intention-to-treat principle. More recently recognized limitations include stopping early for apparent benefit and selective reporting of outcomes according to the results. Key limitations of observational studies include use of inappropriate controls and failure to adequately adjust for prognostic imbalance. Risk of bias may vary across outcomes (e.g., loss to follow-up may be far less for all-cause mortality than for quality of life), a consideration that many systematic reviews ignore. In deciding whether to rate down for risk of bias - whether for randomized trials or observational studies - authors should not take an approach that averages across studies. Rather, for any individual outcome, when there are some studies with a high risk, and some with a low risk of bias, they should consider including only the studies with a lower risk of bias. © 2011 Elsevier Inc. All rights reserved.
Start page
407
End page
415
Volume
64
Issue
4
Language
English
OCDE Knowledge area
Políticas de salud, Servicios de salud
Subjects
Scopus EID
2-s2.0-79951955368
Source
Journal of Clinical Epidemiology
ISSN of the container
08954356
Sources of information:
Directorio de Producción Científica
Scopus